PAION AG is a publicly listed specialty pharmaceutical company developing and aiming to commercialize innovative drugs for out-patient and hospital-based sedation, anesthesia and critical care services.

 

Learn more About PAION

Our Mission

PAION’s mission is to be a leading specialty pharmaceutical company in the fields of anesthesia and critical care by bringing novel products to market to benefit patients, doctors and other stakeholders in healthcare. 

PAION's Strategy & Partnering

GIAPREZA & XERAVA

Teleconference & webcast

13 January 2021

Replay

news

01/12/2021

PAION ANNOUNCES EXCLUSIVE LICENSING AGREEMENT WITH LA JOLLA PHARMACEUTICAL FOR...

DGAP-News: PAION AG / Key word(s): Agreement 12.01.2021 / 13:42 ...

Read more
01/12/2021

​​​​​​​PAION ANNOUNCES EXCLUSIVE LICENSING AGREEMENT WITH LA JOLLA...

PAION AG / Key word(s): Agreement ​​​​​​​PAION ANNOUNCES...

Read more
01/07/2021

PAION AG: HANA PHARM RECEIVES MARKET APPROVAL FOR REMIMAZOLAM (BYFAVO) IN...

PAION AG / Key word(s): Regulatory Approval PAION AG: HANA PHARM...

Read more

PAION Chart

Load Chart

I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our privacy policy.